Effectiveness of meningitis vaccine Bexsero in infants in UK national meningitis B immunisation programme

Trial Profile

Effectiveness of meningitis vaccine Bexsero in infants in UK national meningitis B immunisation programme

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Meningococcal vaccine group B OMV Novartis (Primary)
  • Indications Meningitis; Meningococcal group B infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2016 Results published in the Internet Document
    • 26 Sep 2016 New trial record
    • 05 Sep 2016 Prelimiary data were presented at the International Pathogenic Neisseria Conference (IPNC) 2016, according to a GlaxoSmithKline media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top